Theia Ventures declared that it had spearheaded a pre-seed investment in Lemnisca, a startup bio-AI company developing intelligent solutions to expand biomanufacturing. Dr. Satakarni Makkapati and PointOne Capital also participated in this round. Lemnisca’s Bengaluru lab, AI platform development, and early trials to scale sustainable bioproduction will all be supported by this grant.
The investment demonstrates Theia’s dedication to supporting innovative technologies that facilitate sustainable industrial output.
Lemnisca is developing an AI fermentation companion that will enable producers to grow bioprocesses more quickly, reliably, and effectively. Scalable biomanufacturing has become crucial as businesses transition to biological substitutes for petrochemicals and renewable feedstocks.
AI has sped up the identification of new molecules, but moving these advancements quickly and reliably from the lab to the industrial scale is currently a major barrier. In order to comprehend process biology and direct production in real time, Lemnisca’s science-aware AI collaborates with scientists and operators by combining wet-lab experimentation with dry-lab modeling. The end product is a continuously learning system that improves the efficiency, predictability, and overall dependability of biomanufacturing.
In addition to developing its own internal product pipeline, Lemnisca will first collaborate with fermentation-led producers who are already making progress in their biomanufacturing endeavors.
In order to ensure quick validation and scalable impact, the company wants to cut development timeframes by up to 50%, increase operating efficiency by 25%, and hasten the use of renewable and waste-carbon feedstocks. Currently, CDMOs, OEMs/SIs, and international ingredient brands are invited to participate in pilot projects and form strategic alliances with the company.
British International Investment announced the first closing of Theia Ventures’ new fund last month, and this is its third investment. Sarla Aviation, an electric aircraft firm, and Climitra Carbon, a biochar company serving the steel industry, are the fund’s first two investments. Three more investments are scheduled to be made during this fiscal year.
Leadership Comments
“We are delighted to be early partners in Lemnisca’s journey, where we firmly believe that biomanufacturing in today’s era needs advanced digital simulators that predict how microbial processes will perform before reaching large industrial scale,” said Priya Shah, Partner at Theia Ventures. “The team brings rich practical experience to support the symbiotic development of this product to be applied to nutraceutical markets.”
“From day one, our question was simple: how do we make biomanufacturing the default manufacturing mode globally?” said Pushkar Pendse, Co-founder & CEO, Lemnisca. “Our focus is to build the digital operating system that brings biology from lab to factory, making scale-up faster, smarter, and globally accessible.”
“We are rethinking everything, right from lab workflows to model architectures,” added Shilpa Nargund, Co-founder & CTO, Lemnisca. “The goal is fewer surprises at scale and faster, repeatable success.”
To Know More About Lemnisca: CLICK HERE
